
Shantel Upshaw Houston, PharmD, discusses the vital role of pharmacists in bridging health care gaps and fostering community connections to improve patient care.

Shantel Upshaw Houston, PharmD, discusses the vital role of pharmacists in bridging health care gaps and fostering community connections to improve patient care.

Tripp Logan, PharmD, and Jake Galdo, PharmD, discuss the nuances behind community pharmacy practices and the importance of understanding patient, policymaker, and provider perspectives.

Sponsored Content
Chris Bell, JD, vice president of business operations at API Warehouse, discusses proactive approaches in preventing fraudulent threats and staying compliant with DSCSA.

This year’s event, from October 18-21, 2025, will take place in New Orleans, Louisiana, at the Ernest N. Morial Convention Center.

Pharmacists advocate for standardized scope of practice, improved collaborative care models, and equitable reimbursement to enhance patient services across different states.

This episode explores how recent trends in the retail community pharmacy industry are informing the actions of pharmacy leadership and their teams across the country.

Sponsored Content
Calvin Hunsicker, founder & chief product officer at SureCost, discusses ongoing pharmacy procurement challenges in 2025 and how his company is helping businesses tackle common obstacles.

Community pharmacists are increasingly playing a vital role in expanding health care access by offering clinical services like chronic disease management, HIV prevention, and reproductive health care.

While the new guidelines are reserved for critical care pharmacists in the ICU, they can be applied to other practice areas, highlighting the crucial role pharmacists play in health care.

Researchers conduct a proof-of-concept study exploring the feasibility of health information technology interoperability between a medical office and independent pharmacies.

Andrea Sikora, PharmD, MSCR, FCCM, FCCP, BCCCP, led a 21-member panel on critical care pharmacists and joined us to discuss how guideline updates may impact the greater pharmacy industry.

Along with additional bills to further bolster PBM reform, the organizations are aiming to pass the PBM Reform Act for improved medication costs and community pharmacy sustainability.

The Medicare Drug Price Negotiation Program is anticipated to cause multiple issues for pharmacy owners and their cashflow sustainability.

After experiencing tragedy in his personal life, Bil Schmidtknecht was led to join the community of independent pharmacists and industry advocates calling for PBM reform across both aisles.

Regardless of which stakeholders are involved, a collective, team effort is necessary to achieve state- and federal-level PBM reform.

From the perspective of someone directly impacted by PBM practices, Bil Schmidtknecht shares his insights into the ways PBMs affect patients’ access to medications.

After sharing his son’s tragic story, Bil Schmidtknecht discusses the common ways the Big 3 PBMs operate and how smaller organizations are on the rise, becoming unlikely competitors.

Bil Schmidtknecht joined Drug Topics to share his son’s tragic story and how it motivated him to join the greater fight in putting the lives of patients at the forefront of health care.

Addressing the impacts on patients and the overall pharmacy market, Joey Mattingly, PharmD, MBA, PhD, discusses trends in pharmacies opening and closing across the country.

In part 3 of our interview with Joey Mattingly, PharmD, MBA, PhD, he discusses potential government policies for reducing pharmacy closures.

The event will focus on patient access and education in pharmacy practice, featuring industry leaders providing actionable strategies and real-world solutions for independent pharmacies.

In this episode, host Taylor Watterson, PharmD, PhD, welcomes Josie Quick, CPhT-Adv, CSPT, BUS, an advanced certified pharmacy technician with over 20 years of experience.

Joey Mattingly, PharmD, MBA, PhD, discussed the reasons why pharmacies may open or close and where exactly PBMs fall in line amid common pharmacy turnover trends.

Expert pharmacy business researcher Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to discuss recent trends in pharmacy churn and how it directly impacts patients.

While experts have been measuring the impacts stemming from US pharmacy deserts, they are also working to establish a path forward to reduce closures and increase access.

Sponsored Content
Ryan Bingham, chief operating officer at iA, discusses how his team is advancing technology within the pharmacy to help locations around the country drive efficiency.